Rare Thyroid Therapeutics Email Formats
Pharmaceutical Manufacturing • 
Stockholm, Stockholm County, Sweden • 1-10 Employees
Key Contact at Rare Thyroid Therapeutics
Nicklas Westerholm
CEO and Board member Rare Thyroid Therapeutics AB
Company overview
| Headquarters | Teatergatan 3, Stockholm, Stockholm County 111 48, SE |
| Websites | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Clinical Trials, Neurology, Endocrinology, Pediatric, Orphan Drugs, Pharmaceutical Development, Mct8 Deficiency, Thyroid Hormone Signalling, Ahds |
| Founded | 2017 |
| Employees | 1-10 |
| Socials |
About Rare Thyroid Therapeutics
Rare Thyroid Therapeutics is a privately held pharmaceutical company, developing therapies for rare and neglected thyroid hormone disorders. Our lead product candidate Emcitate® is under development for the treatment of MCT8 deficiency, also called Allan-Herndon-Dudley Syndrome, a rare inborn X-linked disorder caused by a dysfunctional thyroid hormone transporter.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Funding Data
Rare Thyroid Therapeutics has never raised funding before.
Spain
United States
Netherlands
United KingdomFrequently asked questions
Rare Thyroid Therapeutics is located in Stockholm, Stockholm County, SE.
Rare Thyroid Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.
Rare Thyroid Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
